Cite
APA Citation
Maciocia, N., Melville, A., Cheesman, S., Sharpley, F., Ramasamy, K., Streetly, M., Jenner, M., Benjamin, R., Schey, S., Maciocia, P., Popat, R., D'sa, S., Rismani, A., Cerner, A., Yong, K., & Rabin, N. (2017). real‐world use of pomalidomide and dexamethasone in double refractory multiple myeloma suggests benefit in renal impairment and adverse genetics: a multi‐centre UK experience. British journal of haematology, 176, 908–917. http://access.bl.uk/ark:/81055/vdc_100042871576.0x000051